291 related articles for article (PubMed ID: 15857337)
1. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study.
Yilmaz S; Dursun M; Ertem M; Canoruc F; Turhanoğlu A
Int J Clin Pract; 2005 Mar; 59(3):361-9. PubMed ID: 15857337
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological features of irritable bowel syndrome in a Turkish urban society.
Celebi S; Acik Y; Deveci SE; Bahcecioglu IH; Ayar A; Demir A; Durukan P
J Gastroenterol Hepatol; 2004 Jul; 19(7):738-43. PubMed ID: 15209618
[TBL] [Abstract][Full Text] [Related]
3. [An epidemiologic study of irritable bowel syndrome in Beijing - a stratified randomized study by clustering sampling].
Pan G; Lu S; Ke M; Han S; Guo H; Fang X
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):26-9. PubMed ID: 11860753
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.
Han SH; Lee OY; Bae SC; Lee SH; Chang YK; Yang SY; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH; Kim TH
J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
[TBL] [Abstract][Full Text] [Related]
6. [A population-based epidemiologic study of irritable bowel syndrome in Guangdong province].
Xiong LS; Chen MH; Chen HX; Xu AG; Wang WA; Hu PJ
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):278-81. PubMed ID: 15059507
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling.
Pan G; Lu S; Ke M; Han S; Guo H; Fang X
Chin Med J (Engl); 2000 Jan; 113(1):35-9. PubMed ID: 11775207
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of irritable bowel syndrome: a community survey.
Wilson S; Roberts L; Roalfe A; Bridge P; Singh S
Br J Gen Pract; 2004 Jul; 54(504):495-502. PubMed ID: 15239910
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of irritable bowel syndrome in Italian rural and urban areas.
Usai P; Manca R; Lai MA; Russo L; Boi MF; Ibba I; Giolitto G; Cuomo R
Eur J Intern Med; 2010 Aug; 21(4):324-6. PubMed ID: 20603045
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of irritable bowel syndrome in Croatia.
Baretić M; Bilić A; Jurcić D; Mihanović M; Sunić-Omejc M; Dorosulić Z; Restek-Petrović B
Coll Antropol; 2002 Dec; 26 Suppl():85-91. PubMed ID: 12674839
[TBL] [Abstract][Full Text] [Related]
11. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior.
Masud MA; Hasan M; Khan AK
Am J Gastroenterol; 2001 May; 96(5):1547-52. PubMed ID: 11374697
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria.
Bommelaer G; Dorval E; Denis P; Czernichow P; Frexinos J; Pelc A; Slama A; El Hasnaoui A
Gastroenterol Clin Biol; 2002 Dec; 26(12):1118-23. PubMed ID: 12520200
[TBL] [Abstract][Full Text] [Related]
13. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
14. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A; Posserud I; Abrahamsson H; Simrén M
Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
[TBL] [Abstract][Full Text] [Related]
15. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?
Boyce PM; Koloski NA; Talley NJ
Am J Gastroenterol; 2000 Nov; 95(11):3176-83. PubMed ID: 11095338
[TBL] [Abstract][Full Text] [Related]
16. Societal costs for irritable bowel syndrome--a population based study.
Hillilä MT; Färkkilä NJ; Färkkilä MA
Scand J Gastroenterol; 2010 May; 45(5):582-91. PubMed ID: 20166844
[TBL] [Abstract][Full Text] [Related]
17. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway.
Vandvik PO; Lydersen S; Farup PG
Scand J Gastroenterol; 2006 Jun; 41(6):650-6. PubMed ID: 16716962
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of irritable bowel syndrome in a non-Western population.
Husain N; Chaudhry IB; Jafri F; Niaz SK; Tomenson B; Creed F
Neurogastroenterol Motil; 2008 Sep; 20(9):1022-9. PubMed ID: 18492027
[TBL] [Abstract][Full Text] [Related]
20. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
